Clinical Trial Update: Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating anti-coronavirus therapies to prevent progression of COVID-19 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019
• Respiratory Syndrome

Snippet

Sponsor: Population Health Research Institute | Conditions: Coronavirus, Severe Acute Respiratory Syndrome | Phase 3 | Status: COMPLETED